Powering the microbiota market with routine diagnostic solutions
Genetic Analysis AS is a researched driven diagnostic company dedicated to deliver new and innovative diagnostic solutions to the rapidly growing human microbiota market
GA’s mission: ‘Visualizing the human microbiota health by easily accessible and reliable bacteria profiling tools’
Products provided by GA
The GA-map® Dysbiosis Test Lx
Genetic Analysis has developed a CE-marked probe based gut microbiota test on the Luminex® 200 instrument. The technology takes advantage of nucleotide differences in the bacterial 16S rRNA gene to identify predetermined targets.
The GA-map® COVID-19 Fecal Test Kit
The GA-map® COVID-19 Fecal Test is a Qualitative Real Time standardized PCR test for the detection of the 2019 novel coronavirus (SARS-CoV-2) RNA in stool samples and is validated and CE -marked.
Research and Diagnostics
Want to power your routine lab with CE-marked gut microbiota testing?
Contact GA today. Learn about our CE-marked In Vitro Diagnostic test (GA-map® Dysbiosis Test Lx) for diagnosis and characterizing of dysbiosis in IBS and IBD patients.
Curious about gut microbiota’s role in your field of research?
Contact GA today. Learn more about how you can easily map, study and deep dive in the exciting world of microbiota in a clinical setting.
Want to develop your pharmaceutical product to ensure right patient population and target responders only?
Contact GA today. Learn more about how we can co-develop state-of-the art gut microbiota diagnostics to match your drug profile and make sure your product launch is powered with solid data.